Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Correction to Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 23, 2020
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 03, 2020
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
Journal: Journal of medicinal chemistry
Published: March 17, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: January 09, 2018
Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.
Journal: Frontiers in pharmacology
Published: July 24, 2017
Risk of Clostridium difficile infection in intensive care unit patients with sepsis exposed to metronidazole.
Journal: Infectious diseases (London, England)
Published: January 28, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026